CA Ankit Gulgulia (Jain)

By CA Ankit Gulgulia (Jain)

Published on September 22, 2026

For years, Indian retail investors doing fundamental research have relied on third-party platforms — Screener.in, Tickertape, Chartink, and a handful of broker-integrated tools — to filter and analyze the thousands of companies listed on India’s exchanges. Now, the National Stock Exchange (NSE) has entered that space directly with a new beta product: Market Lens, live at marketlens.nseindia.com.

What Is Market Lens?

Market Lens is NSE’s own stock screening platform — a tool that lets investors search, filter, and analyze over 2,000 listed stocks using data sourced directly from the exchange. For anyone who’s spent time on Screener.in, the workflow will feel immediately familiar: pick your criteria, apply filters, and get a ranked list of stocks that match.

The platform is currently in beta, which means the page is live and usable today, but features, presets, and design may continue to evolve as NSE gathers feedback and rolls out updates.

The key differentiator NSE is leaning on is the source of the data itself. Rather than pulling from aggregated or third-party feeds, Market Lens draws on NSE’s own official data — a potential edge for investors who want fewer intermediaries between the exchange and their screen.

Key Features

Search and filter across 2,000+ stocks
At its core, Market Lens lets users apply criteria across NSE’s listed universe to narrow down a broad market into a manageable shortlist.

Pre-built screens
For investors who don’t want to build a strategy from scratch, the platform ships with ready-made screens, including:

  • Growth at a Discount — companies showing growth characteristics while trading at comparatively modest valuations
  • High Promoter Holding + High EPS Growth — a combination screen for businesses where promoters hold a large stake alongside strong earnings growth, often read as a signal of insider confidence paired with fundamental momentum
  • Low Price + High Dividend Cover — stocks trading at lower price points with a comfortable cushion between earnings and dividend payouts

These presets are useful starting points for investors who want a quick, criteria-based read on the market without configuring filters manually.

Sector-based exploration
Market Lens also lets users browse by sector — Pharma, Auto, Banks, IT, and others — with a single tap, useful for quick comparative research within an industry rather than across the whole market.

Custom, saveable screeners
Beyond the presets, users can build their own filter combinations and save them, allowing repeat use of a personalized screening strategy over time.

Why This Matters

A screener launched by the exchange itself marks a notable shift in India’s retail investing landscape. Historically, NSE’s role has been infrastructure and data provision — matching trades, publishing market data, and enabling other platforms to build research tools on top of it. A native screening product changes that positioning, putting NSE in more direct competition with the analytics layer that has grown up around it over the years.

For retail investors, the practical upside is straightforward: one less hop between exchange data and investment research, potentially fewer discrepancies from data lag or third-party processing, and a screener that’s free to access via mobile or desktop browser without needing an account on a separate platform.

How to Access It

Market Lens is live now, in beta, at marketlens.nseindia.com. No separate app download is required — it works directly through both mobile and desktop browsers, making it easy to try out immediately.

The Bigger Picture

Being in beta suggests NSE is still refining the product — expect feature additions, possibly more advanced technical screening tools, and refinements to existing presets as user feedback comes in. Whether Market Lens can match the depth and community-driven query flexibility of platforms like Screener.in, or the technical-analysis strength of Chartink, will likely become clearer as it matures out of beta.

For now, it’s a compelling addition to the toolkit — especially for investors who value screening straight from the source.


Disclosure: This post describes a screening tool and its features; it isn’t investment advice. Always do your own due diligence before acting on any screen or stock idea.

Subscribe
Notify of
guest

0 Comments
Most Voted
Newest Oldest